Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Endologix Inc. ELGXQ

Healthcare
Endologix Inc develops, manufacture, market, and sell innovative medical devices for the treatment of aortic disorders in the United States and internationally. The company only reporting segment that is focused on the development, manufacture, marketing, and sale of EVAR and EVAS products for the treatment of aortic disorders. It product Includes a variety of endovascular stent grafts for the... see more

Recent & Breaking News (OTCPK:ELGXQ)

Endologix Reports Second Quarter 2018 Financial Results

Business Wire August 9, 2018

Endologix, Inc. to Announce Second Quarter 2018 Financial Results on August 9, 2018

Business Wire July 16, 2018

Market Trends Toward New Normal in Endologix, Sanmina, First American Financial, Expeditors International of Washington, Liberty Broadband, and Nu Skin Enterprises — Emerging Consolidated Expectations, Analyst Ratings

GlobeNewswire June 28, 2018

Endologix Reports Positive 1-Year Results from the Ovation® LUCY Study

Business Wire June 28, 2018

Endologix Appoints Jeffry Fecho as Chief Quality Officer

Business Wire June 25, 2018

Analysis: Positioning to Benefit within G-III Apparel Group, LTD, Diebold Nixdorf, Endologix, MACOM Technology Solutions, Halyard Health, and REV Group — Research Highlights Growth, Revenue, and Consolidated Results

GlobeNewswire May 15, 2018

Endologix Appoints John Onopchenko as Chief Executive Officer

Business Wire May 2, 2018

Endologix Reports First Quarter 2018 Financial Results

Business Wire May 2, 2018

Benzinga's Daily Biotech Pulse: SIGA Rallies On FDA Panel Backing, Rigel And Gilead React To Earnings

Benzinga.com  May 2, 2018

The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap

Benzinga.com  April 29, 2018

Endovascular Aneurysm Sealing (EVAS) with Nellix System Associated with Higher Survival than Traditional Endovascular Aneurysm Repair (EVAR) in New Study

Business Wire April 25, 2018

Endologix, Inc. to Announce Third Quarter 2017 Financial Results on November 7, 2017

Business Wire October 10, 2017

Endologix Receives IDE Approval for the EVAS2 Confirmatory Clinical Study to Evaluate the Nellix® EndoVascular Aneurysm Sealing System

Business Wire October 6, 2017

Endologix Announces CE Mark Approval for the Nellix® EndoVascular Aneurysm Sealing System with the Refined Indications for Use

Business Wire September 21, 2017

Healthcare Stock Performance Review -- Glaukos, Endologix, Merit Medical Systems, and HTG Molecular Diagnostics

PR Newswire September 12, 2017

Endologix Announces Collaboration Agreements with Japan Lifeline for the Development and Commercialization of Thoracic Endovascular Systems in Japan

Business Wire September 11, 2017

Endologix Announces Positive Clinical Results from the LEOPARD Clinical Study

Business Wire August 17, 2017

Healthcare Stock Performance Review -- Endologix, Zimmer Biomet, Insulet, and C.R. Bard

PR Newswire August 4, 2017

Endologix Reports Second Quarter 2017 Financial Results

Business Wire August 2, 2017

Investor Network: Endologix, Inc. to Host Earnings Call

Accesswire August 2, 2017